logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million

Annual General Meeting, Investor News 2024-11-15
STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify” or the “Company”) on 23 October 2024 regarding expansion to […]
Read More

Inify Laboratories – notice of Extraordinary General Meeting on December 6, 2024

Annual General Meeting, Investor News 2024-11-15
Stockholm – November 15, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Extraordinary General Meeting on December […]
Read More

Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer

Investor News, News 2024-11-05
STOCKHOLM – November 05, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, is proud to announce a partnership with the ProMort research team at […]
Read More

Panel talk about Inify’s third quarter 2024

Investor News 2024-10-25
Inify Laboratories have decided to establish its operation to the United Kingdom and expand diagnostics to the gastrointestinal field. One of the major challenges in the UK is long and […]
Read More

Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics

Financial reports, Investor News 2024-10-23
STOCKHOLM – October 23, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has after extensive market mapping decided to establish operations in the United […]
Read More

Panel talk about Inify’s second quarter 2024

Investor News 2024-09-09
Inify Laboratories continued to deliver strong growth with sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had […]
Read More

INIFY Laboratories: 62% revenue growth and strong international interest

Financial reports, Investor News 2024-08-21
STOCKHOLM – August 21, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver strong growth, with sales of SEK 3.6 million in […]
Read More

Inify Laboratories AB (publ) – summary of Annual General Meeting

Annual General Meeting, Investor News 2024-05-15
Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 14, 2024. A total of 30,133,104 shares were represented at the […]
Read More

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24
STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]
Read More

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24
STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]
Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    Twitter

© Inify® Laboratories